23 Nov 2020

The Oxford/AstraZeneca vaccine is up to 90% effective, according to interim data

AstraZeneca and Oxford University’s COVID-19 vaccine has concluded the Phase III trial with a 90% effectiveness rate, according to interim data from the trials. The trial also discovered that the vaccine was only 70% effective when the data of two different dosing regimens were combined. The organizations concluded that the

Read More
19 Nov 2020

Covid-19 Vaccine Progress Gives Tokyo Olympics a Tailwind

COVID-19 trial breakthroughs are offering hope to people across the world. Tokyo’s Olympic organizers are looking to acquire vaccines for its athletes who want to compete in the event. However, world leaders remain cautious about whether vaccines will be ready in time and if there will be enough to distribute

Read More
18 Nov 2020

COVID-19 High Performance Computing Consortium Shifts Focus to Patient Outcomes

The COVID-19 High-Performance Computing Consortium was created at the beginning of the pandemic, aiming to allow researchers to access supercomputers to assist them in studies of the infectious virus. The group has announced that it will be moving into the next chapter after eight months of operation, during which it

Read More
17 Nov 2020

Internal email reveals 65 virus cases among WHO Geneva staff

According to a recently exposed internal email, the World Health Organization’s (WHO) headquarters in Geneva has experienced an outbreak infecting 65 employees. The infections include five people who had contact with one another and were working on the premises. The UN Health Agency is currently investigating how the outbreak occurred,

Read More
12 Nov 2020

EU agrees to buy 300 million doses of the Pfizer/BioNTech Covid-19 vaccine

The European Union has announced that it formally authorized a contract with pharmaceutical giant Pfizer. Pfizer has developed a vaccine that boasts a 90% effectiveness rate and has maintained health check clearances throughout Phase 1, 2, and 3 trials. The vaccine was developed in collaboration with German lab BioNTech. The

Read More
11 Nov 2020

In Italy’s Second Coronavirus Wave, Milan Staggers as Hospitals Fill Up

Milan, Italy’s booming business capital, has become the epicenter of the country’s second wave of COVID-19 cases, further risking the country’s economic recovery that began to take hold following the end of the first wave. Italy was one of the first countries to suffer from the pandemic, however, it believed

Read More
10 Nov 2020

Key Palestinian negotiator Saeb Erekat dies of Covid-19

Saeb Erekat, one of the most prominent Palestinian political figures, has died from COVID-19, according to official reports. Erekat was 65 and passed away at the Hadassah Medical Center in Jerusalem after being admitted in October and diagnosed with the virus. Erekat was responsible for leading Palestinians in peace talks

Read More
10 Nov 2020

Brazil suspends trials of China’s Sinovac coronavirus vaccine, citing ‘serious adverse event’

In July, Chinese drugmaker Sinovac Biotech began Phase 3 trials for its COVID-19 vaccine, collaborating with the Brazilian Butantan Institute located in Sao Paulo. However, the Phase 3 trials have been halted due to a serious adverse event involving a volunteer recipient, according to Brazilian media. The trials represent the

Read More
09 Nov 2020

Covid vaccine: First ‘milestone’ vaccine offers 90% protection

Pfizer and BioNTech have developed the first effective COVID-19 vaccine, boasting a success rate of 90% in the preliminary analysis. The vaccine has been tested on over 43,000 people spanning six different countries. No health concerns have been raised throughout the trial process. The companies are now seeking emergency approval

Read More
09 Nov 2020

Biden’s New Covid-19 Task Force, Staffed By Health Experts, To Meet As U.S. Approaches 10 Million Cases

New US President-elect Joe Biden has announced a renewed COVID-19 task force made up of public health experts and doctors. This is seemingly part of Biden’s extensive plan to combat the COVID-19 pandemic as the US creeps towards 10 million total cases amassed over the past several months. The pandemic

Read More